Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Alaunos Therapeutics (TCRT) Return on Assets (2016 - 2025)

Alaunos Therapeutics (TCRT) has disclosed Return on Assets for 15 consecutive years, with 0.96% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets rose 196.0% year-over-year to 0.96%, compared with a TTM value of 0.96% through Sep 2025, up 196.0%, and an annual FY2024 reading of 0.87%, up 12.0% over the prior year.
  • Return on Assets was 0.96% for Q3 2025 at Alaunos Therapeutics, up from 1.18% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.57% in Q3 2022 and bottomed at 3.84% in Q1 2024.
  • Average Return on Assets over 5 years is 1.45%, with a median of 0.96% recorded in 2025.
  • The sharpest move saw Return on Assets crashed -315bps in 2024, then surged 247bps in 2025.
  • Year by year, Return on Assets stood at 0.75% in 2021, then increased by 23bps to 0.58% in 2022, then crashed by -352bps to 2.62% in 2023, then soared by 42bps to 1.53% in 2024, then soared by 37bps to 0.96% in 2025.
  • Business Quant data shows Return on Assets for TCRT at 0.96% in Q3 2025, 1.18% in Q2 2025, and 1.71% in Q1 2025.